
News|Articles|August 1, 2004
Glycemic control and pulmonary function sustained throughout long-term use of inhalable insulin
Two studies evaluating the efficacy and long-term safety of the inhalable, rapid-acting dry powder insulin formulation (Exubera, Pfizer/Aventis) demonstrate that the drug was able to sustain glycemic control and pulmonary function in patients with type 2 diabetes
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Jury Still Out on Effect of GLP-1 Drugs on the Eyes | AAO 2025
2
Advancing Equity and Access in Breast Cancer Care
3
Cobenfy in Practice: Hope, Hurdles, and the Next Chapter in Schizophrenia Care
4
Type 1 Diabetes Drug Tzield Under Expedited Review Through New FDA Program
5